Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.

Autor: Lim YX; Genome Institute of Singapore, Laboratory of Women's Health & Genetics, Singapore 138672, Singapore., Lim ZL; Genome Institute of Singapore, Laboratory of Women's Health & Genetics, Singapore 138672, Singapore., Ho PJ; Genome Institute of Singapore, Laboratory of Women's Health & Genetics, Singapore 138672, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117549, Singapore., Li J; Genome Institute of Singapore, Laboratory of Women's Health & Genetics, Singapore 138672, Singapore.; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Jazyk: angličtina
Zdroj: Cancers [Cancers (Basel)] 2022 Aug 30; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 30.
DOI: 10.3390/cancers14174218
Abstrakt: Close to half (45.4%) of the 2.3 million breast cancers (BC) diagnosed in 2020 were from Asia. While the burden of breast cancer has been examined at the level of broad geographic regions, literature on more in-depth coverage of the individual countries and subregions of the Asian continent is lacking. This narrative review examines the breast cancer burden in 47 Asian countries. Breast cancer screening guidelines and risk-based screening initiatives are discussed.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje